Jeffrey Hubbell
PhD
Eugene Bell Professor, Pritzker School of Molecular Engineering
👥Biography 个人简介
Dr. Jeffrey Hubbell is a leading biomedical engineer who has developed nanoparticle and biomaterial platforms that target lymph nodes to potentiate anti-cancer immune responses. His work on albumin-binding vaccines and polymer-based nanoparticle adjuvants has demonstrated potent tumor regression in preclinical models. He co-founded Vaccinex and other biotechnology companies to translate nanoparticle-based cancer immunotherapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jeffrey Hubbell 的研究动态
Follow Jeffrey Hubbell's research updates
留下邮箱，当我们发布与 Jeffrey Hubbell（University of Chicago）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment